Please assess the completion status of the following clinical trial:

Trial Title: Study of Effects of YisuiShengxueGranules on Thalassemia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Intermedia α-Thalassemia; intermedia β-Thalassemia; severe β-Thalassemia.~2. Syndrome of Deficiency of Liver-yin and Kidney-yin, and Asthenia of Essence and Blood.~3. Male or female, 3-40 years of age.~4. Provision of written informed consent.~Exclusion Criteria:~1. Complications with critical illness such as cerebrovascular disease, cardiovascular disease, hepatic disease, renal disease, malignancy and etc.~2. Allergy to any ingredients of Yisui Shengxue Granules~3. Psychiatric disorder.~4. Blood transfusion in the latest 90 days for severe β-Thalassemia; blood transfusion in the latest 45 days for intermediaβ-Thalassemia or intermedia α-Thalassemia.。~5. Upper respiratory tract infection with temperature higher than 38.5℃ in the latest 45 days.~6. Taking other antianemic agents in the latest 2 months.~7. Participation in any other clinical interventional trial in the latest 1 month.

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- research (Type: None): biological research on the effects of yisuishengxuegranule
- clinical research (Type: None): clinical research on thalassemia

Based on this trial design, predict the completion outcome and termination type (if applicable).